Tradestie Institutional Equity Comparison Engine

RXD vs SDD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RXD Overall Edge

RXD Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares UltraShort Health Care (RXD) driven by superior Momentum & Technical, Options & Structure. Fundamentally, RXD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SDD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RXD sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against SDD sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RXD N/M vs SDD N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner RXD
1Y +26.9% vs -33.9% ยท 52W Pos 29% vs 20%
Options & Structure Winner RXD
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (50th %ile IV)
RXD NYSE Arca
ProShares UltraShort Health Care
Institutional Equity
$11.95
+1.01% 1D
Market Cap N/A
1M Return -11.84%
1Y Return +26.9%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 80.0 Fund 66.0 Flow 50.0 Mom 68.9
SDD NYSE Arca
ProShares UltraShort SmallCap600
Institutional Equity
$9.14
+2.26% 1D
Market Cap N/A
1M Return -4.4%
1Y Return -33.94%
Forward P/E N/M
Unified AI Score
72.7 / 100 BUY
Tech 82.0 Fund 63.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RXD +26.9% SDD -33.94% Spread: +59.33 pp (RXD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RXD TTM Op. Margin: N/A SDD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RXD vs SDD. Trailing 12-month operating profitability (RXD N/A vs SDD N/A) and valuation multiples (RXD N/M vs SDD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RXD (2) vs SDD (1)
Institutional Metric RXD SDD Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 29% ($8โ€“$21) 20% ($8โ€“$15) Stronger Trend RXD
Beta / 30D Volatility Risk Regime -0.21ฮฒ ยท 40% Vol -1.70ฮฒ ยท 43% Vol Lower Realized Risk RXD
Unified Institutional Score Composite Signal 58.1 / 100 (HOLD) 72.7 / 100 (BUY) Higher Composite SDD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RXD vs SDD Buy Guide
RXD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RXD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SDD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SDD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RXD nor SDD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.